Dorsey & Whitney partners James K. Langdon and Michael E. Rowe have stepped in to represent Lifecore Biomedical and other defendants in a pending securities class action. The action, filed July 29 in Minnesota District Court by Pomerantz LLP and Lockridge Grindal Nauen, accuses the defendants of overstating the company's financial position and issuing inaccurate financial statements due to deficient accounting oversight. The case, assigned to U.S. District Judge Jerry W. Blackwell, is 0:24-cv-03028, Carew v. Lifecore Biomedical, Inc. et al.
Biotech & Pharmaceuticals
August 22, 2024, 9:08 AM